Danae is born: Innovation against bladder cancer

Generating new biomarkers for bladder cancer prognosis is crucial for advancing personalized medicine. At Danae Urogenomics, we are committed to continuous innovation in our diagnostic systems to ensure accuracy in the diagnosis and monitoring of this disease. Our clinical studies and research projects allow us to offer increasingly effective solutions. On our blog, we will share relevant news and publications about our scientific advances and collaborations. Follow us to stay up-to-date on the latest developments in the field of urogenital oncology!